Viridian TherapeuticsVRDN
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 169 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, down 1 from Q2 2025. 16 opened new positions and 18 sold out. The largest holders were FMR LLC ($264.3M), BlackRock, Inc. ($117.1M) and Deep Track Capital, LP ($116.1M). 4 famous investors held it, including Lee Ainslie (0.6% of Maverick Capital's portfolio), Ken Fisher (0.0% of Fisher Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $14.5M |
| Exits | 18 | $9.4M |
All 13F filers, Q2 2025 → Q3 2025: 5,251,304 shares bought and 6,601,259 shares sold, net −1,349,955 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 169 holders
| FMR LLC | 0.01% | Add +0.1% | 12,249,355 | $264.3M |
| BlackRock, Inc. | 0.00% | Reduce -1.7% | 5,428,521 | $117.1M |
| Deep Track Capital, LP | 3.24% | No change | 5,380,449 | $116.1M |
| Kynam Capital Management, LP | 7.11% | No change | 4,427,927 | $95.6M |
| Vanguard Group Inc. | 0.00% | Reduce -3.9% | 4,331,983 | $93.5M |
| Venrock Adviser, LLC | 4.72% | No change | 3,882,709 | $83.8M |
| Fairmount Funds Management LLC | 6.72% | No change | 3,459,913 | $74.7M |
| Commodore Capital LP | 3.37% | Reduce -34.4% | 3,200,000 | $69.1M |
| Tang Capital Management LLC | 2.36% | No change | 2,842,925 | $61.4M |
| Paradigm Biocapital Advisors LP | 1.67% | Reduce -4.8% | 2,609,353 | $56.3M |
| State Street Corp. | 0.00% | Add +0.0% | 2,554,166 | $55.1M |
| T. Rowe Price Associates Inc. | 0.01% | Reduce -16.5% | 2,418,104 | $52.2M |
| Novo Holdings A/S | 3.31% | No change | 2,380,000 | $51.4M |
| Maverick Capital | 0.64% | Reduce -2.0% | 2,212,701 | $47.8M |
| Eversept Partners, LP | 3.18% | Add +1.1% | 1,924,306 | $41.5M |
| Alliancebernstein L.P. | 0.01% | Reduce -4.3% | 1,859,458 | $40.1M |
| Geode Capital Management, LLC | 0.00% | Add +1.5% | 1,766,187 | $38.1M |
| Baker Bros. Advisors LP | 0.27% | No change | 1,744,406 | $37.6M |
| Loomis Sayles & Co. L P | 0.04% | Add +15.8% | 1,550,328 | $33.5M |
| Perceptive Advisors LLC | 0.93% | Add +226.8% | 1,462,400 | $31.6M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | Add +10.1% | 1,220,128 | $26.3M |
| Fisher Asset Management | 0.01% | Add +135.6% | 1,201,226 | $25.9M |
| Parkman Healthcare Partners LLC | 2.74% | Reduce -11.1% | 1,154,487 | $24.9M |
| Wellington Management Group LLP | 0.00% | Add +314.9% | 1,122,532 | $24.2M |
| Pictet Asset Management Holding SA | 0.02% | Reduce -17.1% | 1,049,385 | $22.6M |
| Vivo Capital, LLC | 1.71% | No change | 982,576 | $21.2M |
| Deutsche Bank AG | 0.01% | Add +142.3% | 937,467 | $20.2M |
| Marshall Wace, LLP | 0.02% | Reduce -28.0% | 869,188 | $18.8M |
| Candriam S.C.A. | 0.10% | Reduce -0.2% | 860,232 | $18.6M |
| Rice Hall James & Associates, LLC | 1.00% | Add +65.2% | 851,663 | $18.4M |
| Woodline Partners LP | 0.08% | No change | 815,485 | $17.6M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -15.0% | 764,562 | $16.5M |
| 5AM Venture Management, LLC | 5.82% | No change | 736,595 | $15.9M |
| Dimensional Fund Advisors LP | 0.00% | Add +31.5% | 638,777 | $13.8M |
| Northern Trust Corp. | 0.00% | Add +4.0% | 620,862 | $13.4M |
| Rosalind Advisors, Inc. | 4.58% | Reduce -14.3% | 600,000 | $12.9M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +3.7% | 595,361 | $12.8M |
| Yiheng Capital Management, L.P. | 3.57% | No change | 500,261 | $10.8M |
| HighVista Strategies LLC | 2.48% | Reduce -3.1% | 469,335 | $10.1M |
| UBS Group AG | 0.00% | Reduce -16.1% | 447,677 | $9.7M |
| Victory Capital Management Inc. | 0.01% | Reduce -23.4% | 432,420 | $9.3M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 0.71% | No change | 423,272 | $9.1M |
| Panagora Asset Management Inc. | 0.03% | Add +7.3% | 377,711 | $8.2M |
| Royal Bank of Canada | 0.00% | Add +6.6% | 368,601 | $8.0M |
| Driehaus Capital Management LLC | 0.05% | Reduce -8.7% | 344,084 | $7.4M |
| Raymond James Financial Inc. | 0.00% | Reduce -5.8% | 312,759 | $6.7M |
| JPMorgan Chase & Co. | 0.00% | Reduce -25.7% | 309,133 | $6.7M |
| Silverarc Capital Management, LLC | 0.81% | New | 259,509 | $5.6M |
| Affinity Asset Advisors, LLC | 0.52% | Reduce -35.9% | 250,000 | $5.4M |
| Bank of America Corp. | 0.00% | Add +6.5% | 245,759 | $5.3M |
| Ikarian Capital, LLC | 1.07% | Reduce -47.8% | 245,518 | $5.3M |
| BNP Paribas Financial Markets | 0.00% | Add +27.4% | 242,307 | $5.2M |
| Principal Financial Group Inc. | 0.00% | Add +4.7% | 213,329 | $4.6M |
| Barclays PLC | 0.00% | Reduce -9.9% | 208,246 | $4.5M |
| Balyasny Asset Management L.P. | 0.01% | New | 202,821 | $4.4M |
| Bank of New York Mellon Corp | 0.00% | Add +2.4% | 197,170 | $4.3M |
| Kopp Family Office, LLC | 2.72% | Reduce -4.6% | 193,830 | $4.2M |
| Morgan Stanley | 0.00% | Reduce -4.2% | 191,941 | $4.1M |
| Hudson Bay Capital Management LP | 0.03% | Add +46.6% | 175,251 | $3.8M |
| Nuveen, LLC | 0.00% | Reduce -27.5% | 161,868 | $3.5M |
| Macquarie Group Ltd. | 0.00% | Reduce -1.5% | 154,739 | $3.3M |
| Hennion & Walsh Asset Management, Inc. | 0.12% | Reduce -8.3% | 154,338 | $3.3M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -26.9% | 138,980 | $3.0M |
| Millennium Management | 0.00% | Add +129.3% | 136,280 | $2.9M |
| Russell Investments Group, Ltd. | 0.00% | Add +53.6% | 134,997 | $2.9M |
| Knott David M Jr | 1.05% | Add +27.4% | 116,574 | $2.5M |
| Swiss National Bank | 0.00% | Add +1.6% | 110,700 | $2.4M |
| Wells Fargo & Company | 0.00% | Add +32.7% | 105,880 | $2.3M |
| Rhumbline Advisers | 0.00% | Reduce -2.8% | 104,360 | $2.3M |
| ADAR1 Capital Management, LLC | 0.22% | Reduce -40.4% | 101,704 | $2.2M |
| Susquehanna Fundamental Investments, LLC | 0.09% | Reduce -9.4% | 101,083 | $2.2M |
| Merck & Co., Inc. | 0.88% | No change | 93,414 | $2.0M |
| Propel Bio Management, LLC | 1.94% | New | 90,000 | $1.9M |
| Velan Capital Investment Management LP | 1.75% | No change | 86,500 | $1.9M |
| Boothbay Fund Management, LLC | 0.05% | Reduce -54.2% | 83,594 | $1.8M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +6.3% | 83,500 | $1.8M |
| Invesco Ltd. | 0.00% | Add +29.9% | 80,792 | $1.7M |
| TD Asset Management Inc | 0.00% | Reduce -12.1% | 78,800 | $1.7M |
| Citadel Advisors | 0.00% | Reduce -88.1% | 77,373 | $1.7M |
| Moody Aldrich Partners LLC | 0.30% | Reduce -16.9% | 74,113 | $1.6M |
| J. Goldman & Co LP | 0.06% | Reduce -30.5% | 70,026 | $1.5M |
| Rafferty Asset Management, LLC | 0.00% | Reduce -10.9% | 68,065 | $1.5M |
| Y-Intercept (Hong Kong) Ltd | 0.03% | Add +430.3% | 64,594 | $1.4M |
| SG Americas Securities, LLC | 0.01% | Add +411.8% | 62,118 | $1.3M |
| DCF Advisers, LLC | 0.51% | No change | 62,029 | $1.3M |
| Legal & General Group Plc | 0.00% | No change | 59,983 | $1.3M |
| Knights of Columbus Asset Advisors LLC | 0.07% | Add +2.4% | 59,410 | $1.3M |
| State of Wisconsin Investment Board | 0.00% | Add +10.7% | 56,905 | $1.2M |
| California State Teachers Retirement System | 0.00% | Add +0.0% | 53,692 | $1.2M |
| Susquehanna Portfolio Strategies, LLC | 0.02% | No change | 52,571 | $1.1M |
| J. Safra Sarasin Holding AG | 0.02% | Reduce -69.8% | 51,703 | $1.1M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -58.3% | 57,928 | $1.1M |
| American Century Companies Inc. | 0.00% | Reduce -51.0% | 51,236 | $1.1M |
| Walleye Capital LLC | 0.01% | Reduce -21.6% | 50,643 | $1.1M |
| Simplify Asset Management Inc. | 0.02% | New | 50,000 | $1.1M |
| MetLife Investment Management, LLC | 0.00% | No change | 43,629 | $942K |
| Alps Advisors Inc. | 0.00% | Reduce -9.1% | 39,961 | $862K |
| Susquehanna International Group, LLP | 0.00% | Reduce -70.1% | 37,640 | $812K |
| Graham Capital Management, L.P. | 0.04% | Reduce -32.1% | 37,490 | $809K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Reduce -14.2% | 35,862 | $774K |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.